| Trial ID: | L0900 |
| Source ID: | NCT02132442
|
| Associated Drug: |
Ergocalciferol
|
| Title: |
Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes
|
| Acronym: |
VDLS
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type 2 Diabetes;Nonalcoholic Fatty Liver Disease;Vitamin D Deficiency;Type 2 Diabetes;Nonalcoholic Fatty Liver Disease;Vitamin D Deficiency;Type 2 Diabetes;Nonalcoholic Fatty Liver Disease;Vitamin D Deficiency;Type 2 Diabetes;Nonalcoholic Fatty Liver Dise
|
| Interventions: |
Dietary Supplement: Ergocalciferol, placebo;Dietary Supplement: Ergocalciferol, placebo;Dietary Supplement: Ergocalciferol, placebo;Dietary Supplement: Ergocalciferol, placebo
|
| Outcome Measures: |
Change in hepatic triglyceride content (HTGC);Change in hepatic triglyceride content (HTGC);Change in hepatic triglyceride content (HTGC)Hemoglobin A1c
|
| Sponsor/Collaborators: |
University of Massachusetts, Worcester
|
| Gender: |
All
|
| Age: |
10 Years50 Years
|
| Phases: |
Phase 3
|
| Enrollment: |
12
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
05/05/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
United States;United States;United States;United States;United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02132442
|
